In The News
CBA class action judge used ‘far too onerous’ test, appeals court told
Fletcher can’t pry into judge’s background as law firm class action head
‘Out of licence and out of control’: Maxim seeks injunction against licensee
Court OKs stolen wages settlement, holds off on ‘eye-watering’ fees
ASIC takes NAB to court over customer hardship claims
Seven settles lawsuit by ex-Spotlight reporter
Class action over ‘cookie cutter’ legal advice says declassing application should wait
Holding Redlich adds two MinterEllison partners to Canberra team
Settlement reached with ‘highly unethical’ mastermind of Banksia class action
Full Court cites ‘wider relevance’ of copy and paste judgment
Please login to bookmarkClose

Novartis wants to appeal a ruling in its dispute with generic drug maker Pharmacor over patents for its multiple sclerosis drug Gilenya that tossed three of its four experts out of an upcoming so-called hot tub.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au